I

INCY

Incyte Corporation
HealthcareBiotechnology|NASDAQ Global Select|US

Price

$95.93

Market Cap

$19.09B

Beta

0.86

P/E

14.6

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+21.22%
EPS Growth (YoY)+500.00%
Revenue CAGR 3Y+14.84%
P/E Ratio14.6
PEG Ratio0.03
FCF Yield+7.10%
Debt / Equity0.01
Interest Coverage558.1x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for INCY.

INCY — Incyte Corporation Stock Analysis | Tessera Alpha